Hyperbaric Oxygen Treatment is Associated with Lipid Inflammatory Response Assessed Uding Serum Platelet Activating Factor

1. Sjöberg F, Singer M. The medical use of oxygen: a time for critical reappraisal. J Intern Med. 2013 Dec;274(6):505-28. doi: 10.1111/joim.12139;10.1111/joim.1213924206183Open DOISearch in Google Scholar

2. Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci. 2012 Feb 29;8(1):138-53. doi: 10.5114/aoms.2012.27294;10.5114/aoms.2012.27294Search in Google Scholar

3. Allen MW, Golembe E, Gorenstein S, Butler GJ. Protective effects of hyperbaric oxygen therapy (HBO2) in cardiac care-a proposal to conduct a study into the effects of hyperbaric preconditioning in elective coronary artery bypass graft surgery (CABG). Undersea Hyperb Med.2015 Mar-Apr; 42.107-114. doi:10.2214/ajr.151.5.1003;10.2214/ajr.151.5.10033262997Open DOISearch in Google Scholar

4. Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev. 2016;2016:3565127. doi: 10.1155/2016/3565127;10.1155/2016/3565127487748227247702Open DOISearch in Google Scholar

5. Rahal A, Kumar A, Singh V et al. Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int. 2014;2014:761264. doi: 10.1155/2014/761264;10.1155/2014/761264Search in Google Scholar

6. Dennog C, Hartmann A, Frey G, Speit G. Detection of DNA damage after hyperbaric oxygen (HBO2) therapy. Mutagenesis. 1996 Nov;11(6):605-609. doi:10.10193;896243110.1093/mutage/11.6.6058962431Search in Google Scholar

7. Narkowicz CK, Vial JH, McCartney PW. Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun. 1993;19(2):71-80. PMID: 8225040 doi:10.3109/10715769309056501;10.3109/107157693090565018225040Open DOISearch in Google Scholar

8. Simsek K, Ozler M, Ucar E, et al. Pressure-related effects of hyperbaric oxygen exposure on oxidation products and antioxidant enzymes in the rat lung. J Exp Integr Med. 2011; 1(1):37-42 doi:10.5455/jeim.130111.or.003;10.5455/jeim.130111.or.003Search in Google Scholar

9. Simsek K, Ozler M, Yildirim AO et al. Evaluation of the oxidative effect of long term repetitive hyperbaric oxygen exposures on different brain regions of rats. Scientific World Journal. 2012;2012:849183. doi:10.1100/2012/849183;10.1100/2012/849183Search in Google Scholar

10. Eren E, Ellidag HY, Aydin O, Yilmaz N. HDL functionality and crystal-based sterile inflammation in atherosclerosis. Clin Chim Acta. 2015 Jan 15;439,18-23. doi: 10.1016/j.cca.2014.09.024;10.1016/j.cca.2014.09.024Search in Google Scholar

11. McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018 Mar 27. pii: S0891-5849(18)30145-X. doi: 10.1016/j.freeradbiomed.2018.03.042;10.1016/j.freeradbiomed.2018.03.04229601945Open DOISearch in Google Scholar

12. Tsoupras A, Lordan R, Zabetakis I. Inflammation, not cholesterol, is a cause of chronic disease. Nutrients. 2018 May 12;10(5). pii: E604. doi: 10.3390/nu10050604;10.3390/nu10050604Search in Google Scholar

13. Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA. The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants. Infect Disord Drug Targets. 2009 Aug;9(4):390-9. doi:10.2174/187152609788922555;10.2174/18715260978892255519689381Open DOISearch in Google Scholar

14. Palur Ramakrishnan AV, Varghese TP, Vanapalli S, Nair NK, Mingate MD. Platelet activating factor: A potential biomarker in acute coronary syndrome? Cardiovasc Ther. 2017 Feb;35(1):64-70. doi: 10.1111/1755-5922.12233;10.1111/1755-5922.1223327790832Open DOISearch in Google Scholar

15. Nakamura T, Murata T. Regulation of vascular permeability in anaphylaxis. Br J Pharmacol. 2018 Jul;175(13):2538-2542 doi: 10.1111/bph.14332;10.1111/bph.14332600365429671869Open DOISearch in Google Scholar

16. Bulger EM, Maier RV. Lipid mediators in the pathophysiology of critical illness. Crit Care Med. 2000 Apr;28(4 Suppl):N27-36 doi:10.1097/00003246-200004001-00004;10.1097/00003246-200004001-0000410807314Open DOISearch in Google Scholar

17. Papakonstantinou VD, Lagopati N, Tsilibary EC, Demopoulos CA, Philippopoulos AI. A review on platelet activating factor inhibitors: could a new class of potent metal-based anti-inflammatory drugs induce anticancer properties? Bioinorg Chem Appl. 2017;2017:6947034, doi: 10.1155/2017/6947034;10.1155/2017/6947034538781528458618Open DOISearch in Google Scholar

18. Gao ZX, Rao J, Li YH. Hyperbaric oxygen preconditioning improves postoperative cognitive dysfunction by reducing oxidant stress and inflammation. Neural Regen Res. 2017 Feb;12(2):329-336 doi: 10.4103/1673-5374.200816;10.4103/1673-5374.200816536152028400818Open DOISearch in Google Scholar

19. Yildirim G, Baştuğ M, Akçil IE, Fiçicilar H, Koç E, Zaloğlu N. Does the plateletactivating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. Biol Trace Elem Res. 2000 Winter;78(1-3):7-12. doi:10,1385/BTER:78:1-3:7;10.1385/BTER:78:1-3:7Search in Google Scholar

20. Yildirim G, Koç E, Baştug M, Fiçicilar H, Akçil IE, Zaloglu N. Effects of plateletactivating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. Undersea Hyperb Med. 2000 Fall;27(3):155-8.doi.org/10.22462/01.02.2018.6;Search in Google Scholar

21. Eren E, Yilmaz N, Aydin O. High density lipoprotein and it’s dysfunction. Open Biochem J. 2012;6.78-93 doi: 10,2174/1874091X01206010078;10.2174/1874091X01206010078341480622888373Search in Google Scholar

22. Keskin K, Kilci H, Aksan G, et al. Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy. Turk Kardiyol Dern Ars. 2017 Sep;45(6):533-537. doi: 10.5543/tkda.2017.28302;10.5543/tkda.2017.2830228902644Open DOISearch in Google Scholar

23. Matzi V, Greilberger JF, Lindenmann J, et al. Application of hyperbaric oxygen reduce oxidative damage of plasmatic carbonyl proteins and 8-OHdG by activating glutathion peroxidase. Clin Lab. 2015;61(5-6):587-93.doi:10.7754/Clin.Lab.2014.140929;10.7754/Clin.Lab.2014.140929Search in Google Scholar

24. Kudchodkar B, Jones H, Simecka J, Dory L. Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol. 2008 Sep;128(3):435-41. doi: 10.1016/j.clim.2008.05.004; Epub 2008 Jul 2;10.1016/j.clim.2008.05.004;Epub2008Jul2Open DOISearch in Google Scholar

25. Kudchodkar BJ, Pierce A, Dory L. Chronic hyperbaric oxygen treatment elicits an antioxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis. 2007 Jul;193(1):28-35. doi:10.1016/j.atherosclerosis.2006.08.018;10.1016/j.atherosclerosis.2006.08.018Open DOISearch in Google Scholar

26. Snyder F.Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990 Nov;259 (5 Pt 1):C697-708.doi:10.1152/ajpcell.1990.259.5.C697;10.1152/ajpcell.1990.259.5.697Open DOISearch in Google Scholar